<DOC>
	<DOCNO>NCT02849821</DOCNO>
	<brief_summary>This prospective , control observational study . Participants underwent 3-hour exposure hypoxic condition simulate altitude 4,000 meter sea level ( m.a.s.l . ) hypobaric pressure chamber . Clinical parameter , well blood stool sample biopsy sigmoid colon ( sigmoidoscopy ) collect subsequent time point . The investigator goal evaluate 3-hour stay high altitude ( 4 , 000 ) alter disease activity modulate pro inflammatory reaction .</brief_summary>
	<brief_title>The Altitude Inflammatory Bowel Disease Study</brief_title>
	<detailed_description>To evaluate potential influence hypoxia course IBD biomolecular level , test effect hypoxia standardized condition , investigator initiate prospective control investigation healthy control IBD patient stable remission . investigator primary aim show 3-hour stay high altitude alter disease activity IBD . Ten healthy volunteer , 11 Crohn 's disease ( CD ) patient 9 ulcerative colitis ( UC ) patient underwent 3-hour exposure hypoxic condition simulate altitude 4,000 m.a.s.l . hypobaric low-pressure chamber situate Swiss Aeromedical Center , Dubendorf , Switzerland . Stool sample analysis calprotectin microbiotal composition , biopsy sample rectosigmoid region , blood sample repetitively collect analysed conjunction detail record clinical symptom subsequent interval 4 week .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>diagnosis Crohn 's disease ulcerative colitis least 6 month prior inclusion give write consent clinical remission ( measure Harvey Bradshaw Activity Index ( HBI ) CD partial Mayo Score UC ) contraindication sigmoidoscopy intercurrent bacterial viral intestinal disease ( culture serology ) pregnant breast feeding severe concomitant disease exclude participate study mean study physician likely show cooperation study procedure active infection systemic antibiotic , antiviral antifungal treatment 3 week baseline suffer shortbowel syndrome receive parenteral nutrition clinical condition allow stay height 4,000 m.a.s.l . claustrophobic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>